Clavicle fractures are common, comprising 2%-4% of all fractures.[@bib36] The majority are midshaft fractures; however, injuries to the distal or medial fragment also occur.[@bib64]^,^[@bib110] Clavicle fractures mostly occur in male individuals younger than 30 years, with an increased incidence, regardless of sex, above age 70 years.[@bib36] Historically, nonoperative methods were used to treat these injuries, as they were seen to have low rates of nonunion.[@bib61]^,^[@bib70]^,^[@bib92] However, some studies have shown unsatisfactory results with such treatments, including pain, cosmetic complaints, and brachial plexus irritation.[@bib27]^,^[@bib42] Recent studies have suggested that surgery shows certain benefits, such as a quicker return of function, increased patient satisfaction, and fewer complications.[@bib55]^,^[@bib80]^,^[@bib110] Given the expected increase in the population of higher-risk groups, identifying an optimal treatment plan will become of greater importance.[@bib52]

Multiple interventions are available to treat clavicle fractures, and options can vary depending on the location of the injury (ie, medial, midshaft, or distal).[@bib28]^,^[@bib47]^,^[@bib62]^,^[@bib80] Determining the best approach is a complex decision, as both patient-reported and clinical outcomes are important to consider. Past trials and reviews have compared different operative techniques with each other or compared surgery with nonoperative protocols[@bib28]^,^[@bib31]^,^[@bib32]; however, there exist few reviews that have examined these specific interventions all at once.

The aim of this systematic review and meta-analysis was to compare management options for medial, midshaft, and distal clavicle fractures to help inform future treatment plans.

Methods {#sec1}
=======

Literature search {#sec1.1}
-----------------

We searched the Embase, MEDLINE, and Cochrane databases ([Supplementary Appendix S1](#appsec1){ref-type="sec"}), from database inception to March 14, 2019. We also identified a recent review on distal fractures with similar methodology and eligibility criteria[@bib7] and performed an update of their search on March 15, 2019. After article screening, we did not identify any comparative studies on medial fractures; therefore, we performed another search ([Supplementary Appendix S2](#appsec1){ref-type="sec"}) on April 9, 2019, for studies on this injury.

Eligibility criteria {#sec1.2}
--------------------

Initially, we included studies that (1) were comparative, examining at least 2 treatments for medial, midshaft, or distal clavicle fractures; (2) had an experimental or observational study design; (3) focused on skeletally mature patients; and (4) were published in English. As stated earlier, after article screening, we did not find any comparative studies on medial clavicle fractures. We performed another search for such studies using similar eligibility criteria, except that these studies were case series or case reports.

Article selection {#sec1.3}
-----------------

Two reviewers screened titles, abstracts, and full-text articles, with discrepancies resolved through discussion.

Data extraction {#sec1.4}
---------------

We extracted study characteristics (ie, author, location, study length, and inclusion and exclusion criteria), patient characteristics (ie, age, sex, and fracture type), and outcome data (ie, patient-reported pain or function, time to union or return to work, and complications).

Statistical analysis {#sec1.5}
--------------------

For midshaft and distal fractures, we conducted random-effects Bayesian network meta-analyses, with 95% credible intervals (CrIs). We calculated risk ratios for dichotomous variables and mean differences for continuous data. We represented heterogeneity as *I*^2^ values and calculated the surface area under the cumulative ranking curve (SUCRA) values.[@bib53] We conducted analyses using the "gemtc" package in R (version 3.5.0 \[2018\]; R Foundation for Statistical Computing, Vienna, Austria). For medial fracture studies, we described their results qualitatively.

Results {#sec2}
=======

Search results {#sec2.1}
--------------

Our search retrieved 983 references, but 125 were duplicates. We included 117 for full-text review. We then deemed 62 articles eligible, with 52 on midshaft fractures and 10 on distal fractures; however, for distal fractures, we already identified 5 of them from the prior review, leaving 5 new studies on distal fractures. In addition, another study on midshaft fractures was identified by one of us from another source, leaving 53 included articles on midshaft fractures in this review ([Fig. 1](#fig1){ref-type="fig"}).[@bib1], [@bib2], [@bib3], [@bib4]^,^[@bib6]^,^[@bib9]^,^[@bib11], [@bib12], [@bib13], [@bib14], [@bib15]^,^[@bib17]^,^[@bib19]^,^[@bib20]^,^[@bib24], [@bib25], [@bib26]^,^[@bib34]^,^[@bib35]^,^[@bib37]^,^[@bib38]^,^[@bib40]^,^[@bib41]^,^[@bib43]^,^[@bib44]^,^[@bib46]^,^[@bib50]^,^[@bib54]^,^[@bib56], [@bib57], [@bib58], [@bib59], [@bib60]^,^[@bib65]^,^[@bib68]^,^[@bib71]^,^[@bib73]^,^[@bib75]^,^[@bib77]^,^[@bib79]^,^[@bib80]^,^[@bib83]^,^[@bib84]^,^[@bib87]^,^[@bib91]^,^[@bib93]^,^[@bib94]^,^[@bib97]^,^[@bib100], [@bib101], [@bib102], [@bib103]^,^[@bib108] One article was a secondary publication of a study, so we included 52 unique studies.[@bib73]Figure 1Flow diagram of included studies from initial search.

From the study by Boonard et al[@bib7] on distal fractures, we included 11 studies. After updating their search, we retrieved 18 references for screening but 2 were duplicates. We included 4 for full-text review. We then deemed 3 articles eligible, although 1 was a duplicate of an already included study, so only 2 were new studies. Thus, in addition to the 5 studies from our first search, we identified 18 studies on distal fractures ([Fig. 2](#fig2){ref-type="fig"}).[@bib10]^,^[@bib18]^,^[@bib21]^,^[@bib22]^,^[@bib29]^,^[@bib30]^,^[@bib39]^,^[@bib45]^,^[@bib48]^,^[@bib69]^,^[@bib74]^,^[@bib82]^,^[@bib85]^,^[@bib86]^,^[@bib90]^,^[@bib104]^,^[@bib106]^,^[@bib107]Figure 2Flow diagram of included studies from distal clavicle fracture search.

From the medial fracture search, we retrieved 354 references; however, 8 were duplicates and 60 were conference abstracts or reviews. We included 51 articles for full-text review and deemed 16 eligible for inclusion ([Fig. 3](#fig3){ref-type="fig"}).[@bib5]^,^[@bib8]^,^[@bib23]^,^[@bib49]^,^[@bib51]^,^[@bib63]^,^[@bib67]^,^[@bib76]^,^[@bib78]^,^[@bib81]^,^[@bib88]^,^[@bib89]^,^[@bib95]^,^[@bib99]^,^[@bib105]^,^[@bib109]Figure 3Flow diagram of included studies from medial clavicle fracture search.

Study characteristics {#sec2.2}
---------------------

The characteristics of the studies on midshaft fractures are shown in [Table I](#tbl1){ref-type="table"}. The studies were published from 1987 to 2019, and sample sizes ranged from 22 to 302 patients. Six interventions were identified: elastic stable intramedullary nail (ESIN), intramedullary pin (IMP), Sonoma CRx intramedullary nail (CRx; Sonoma Orthopedic Products, Santa Rosa, CA, USA), plating, figure-of-8 bandage (F8B), and sling. Some studies evaluated the use of an F8B and sling in combination. In terms of patient demographic characteristics, the average age across studies ranged from 24 to 60 years (median, 36 years) and the proportion of male patients ranged from 10% to 100% (median, 79%). The outcomes reported on that we analyzed were as follows: pain and function (at ≤4, 6, 12, 24, 52, and \>52 weeks), time to radiographic union, time to return to work, delayed union, malunion, nonunion, refracture, revision, and symptoms.Table IStudy characteristics of midshaft clavicle fracture studiesAuthors, yearLocation of studyStudy designSample sizeTreatments evaluatedLength of study follow-upAge, yrMale sex, %Ahrens et al,[@bib1] 2017United KingdomRandomized trial302Plate9 moMean, 36 ± 1286SlingMean, 36 ± 1288Andersen et al,[@bib2] 1987DenmarkRandomized trial61F8B3 moMedian, 19 (range, 14-81)NRSlingMedian, 19 (range, 14-66)Andrade-Silva et al,[@bib3] 2015BrazilRandomized trial59Plate12 moMean, 31 ± 1285ESINMean, 28 ± 973Assobhi,[@bib4] 2011FinlandRandomized trial38Plate12 moMean, 33 ± 6 (range, 26-49)89ESINMean, 30 ± 5 (range, 24-45)84Bhardwaj et al,[@bib6] 2018IndiaRandomized trial69Plate24 moMean, 3222SlingMean, 3239Calbiyik et al,[@bib9] 2017TurkeyRandomized trial75CRx12 moMean, 42 ± 1460PlateMean, 39 ± 763Chen et al,[@bib11] 2018ChinaRandomized trial54PlateMean, 15 mo (range, 12-24 mo)Mean, 38 ± 1159ESINMean, 39 ± 1156Chen et al,[@bib12] 2011ChinaRandomized trial60ESINMean, 15 mo (range, 10-20 mo)Mean, 39 ± 1253SlingMean, 38 ± 1353Chen et al,[@bib13] 2012ChinaObservational141ESIN24 moMean, 34 (range, 20-59)72PlateMean, 37 (range, 19-63)73Chu et al,[@bib14] 2018TaiwanObservational120Plate6 moMean, 46 ± 1763F8BMean, 50 ± 1573Coppa et al,[@bib15] 2017ItalyObservational58IMPMean, 47 mo (range, 23-74 mo)Mean, 40 ± 1693F8BMean, 37 ± 1683Eden et al,[@bib17] 2015GermanyObservational102F8B12 moMean, 41 ± 18NRPlateMean, 38 ± 15ESINMean, 34 ± 15Ersen et al,[@bib19] 2015TurkeyRandomized trial60F8BMean, 8 mo (range, 6-12 mo)Mean, 34 (range, 16-75)79SlingMean, 29 (range, 15-72)83Ferran et al,[@bib20] 2010United KingdomQuasi-randomized32IMP12 moMean, 24 (range, 13-42)82PlateMean, 35 (range, 16-53)87Fu et al,[@bib24] 2012TaiwanObservational103IMPMean, 15 mo (range, 12-153 mo)Mean, 35 ± 1572PlateMean, 40 ± 1566Fuglesang et al,[@bib25] 2017NorwayRandomized trial123Plate12 moMean, 35 (range, 16-59)81ESINMean, 36 (range, 16-57)90Hanselman et al,[@bib26] 2016United StatesObservational157PlateUp to 5 yrNRNRIMPJones et al,[@bib34] 2014United KingdomObservational57PlateMean, 30 mo (range, 12-54 mo)Mean, 27 ± 884ESINJudd et al,[@bib35] 2009United StatesRandomized trial70IMP12 moMean, 28 (range, 19-40)93SlingMean, 25 (range, 17-41)89Khorami et al,[@bib37] 2014IranRandomized trial87F8B6 moMean, 3277PlateMean, 3171King et al,[@bib38] 2019TurkeyRandomized trial87CRx15 moMean, 29 ± 1474PlateMean, 35 ± 1254Kleweno et al,[@bib40] 2011United StatesObservational32IMPMean, 8 mo (range, 3-28 mo)Mean, 35 (range, 16-56)71PlateMean, 17 mo (range, 4-58 mo)Mean, 28 (range, 16-46)83Kulshrestha et al,[@bib41] 2011IndiaObservational73Plate18 moMean, 32 ± 696SlingMean, 33 ± 586Lechler et al,[@bib43] 2016GermanyObservational47ESINMean, 38 moMean, 36 ± 1572PlateMean, 39 ± 1564Lee et al,[@bib44] 2008TaiwanQuasi-randomized103IMP12 moMean, 4066PlateMean, 3863Lee et al,[@bib46] 2007TaiwanQuasi-randomized69IMP30 moMean, 60 (range, 50-81)59PlateMean, 57 (range, 52-79)57Liu et al,[@bib50] 2010TaiwanObservational110ESINMean, 18 mo (range, 12-27 mo)Mean, 34 ± 14 (range, 16-65)63PlateMean, 32 ± 10 (range, 17-58)49McKee et al,[@bib54] 2007; Schemitsch et al,[@bib73] 2011CanadaRandomized trial132Sling12 moMean, 3469PlateMean, 3486Melean et al,[@bib56] 2015ChileRandomized trial76Sling12 moMean, 37 ± 11NRPlateMean, 38 ± 13Mirzatolooei,[@bib57] 2011IranRandomized trial60Sling12 moMean, 3510PlateMean, 3621Napora et al,[@bib58] 2018United StatesObservational138Sling≥12 moRange, 16-71NRPlateRange, 16-71Narsaria et al,[@bib59] 2014IndiaRandomized trial66Plate24 moMean, 40 ± 11 (range, 18-64)79ESINMean, 39 ± 9 (range, 20-62)73Naveen et al,[@bib60] 2017IndiaNonrandomized controlled trial60F8B and sling6 moMean, 3590PlateMean, 3287Qvist et al,[@bib65] 2018DenmarkRandomized trial150Sling12 moMean, 39 (range, 18-60)92PlateMean, 40 (range, 18-60)100Robinson et al,[@bib68] 2013United KingdomRandomized trial200Sling12 moMean, 33 ± 1388PlateMean, 32 ± 1187Saha et al,[@bib71] 2014IndiaQuasi-randomized80Plate24 moMean, 33 ± 13 (range, 15-58)NRESINMean, 33 ± 12 (range, 15-55)Shetty et al,[@bib75] 2017IndiaRandomized trial30F8B and sling6 moNRNRPlateSilva et al,[@bib77] 2011BrazilRandomized trial22Plate6 moNRNRESINSmekal et al,[@bib79] 2011AustriaRandomized trial120Sling24 moMean, 38 ± 1585ESINMean, 37 ± 1390Smekal et al,[@bib80] 2009AustriaRandomized trial60Sling24 moMean, 40 ± 1587ESINMean, 36 ± 1287Tabatabaei and Shalamzari,[@bib83] 2011IranNonrandomized controlled trial68IMPMean, 14 moMean, 2984PlateMean, 2784Tamaoki et al,[@bib84] 2017BrazilRandomized trial117F8B12 moMean, 35 ± 1381PlateMean, 31 ± 1090Tarng et al,[@bib87] 2012TaiwanObservational57Plate12 moMean, 47 (IQR, 37-59)56ESINMean, 38 (IQR, 27-58)40Tutuhatunewa et al,[@bib91] 2017The NetherlandsObservational278SlingMedian, 26 mo (range, 15-41 mo)Median, 42 (IQR, 26-56)78PlateMedian, 27 mo (range, 18-37 mo)Median, 40 (IQR, 24-50)86van der Meijden et al,[@bib93] 2015The NetherlandsRandomized trial120Plate12 moMean, 38 ± 1591ESINMean, 40 ± 1397Van Der Ven Denise et al,[@bib94] 2015The NetherlandsObservational97SlingMean, 60 moMean, 41 ± 1585PlateMean, 41 ± 1390Virtanen et al,[@bib97] 2012FinlandRandomized trial60Sling12 moMean, 33 ± 1288PlateMean, 41 ± 1186Wang et al,[@bib100] 2015TaiwanObservational55Plate12 moMean, 35 (range, 16-60)70ESINMean, 42 (range, 16-66)68Wenninger et al,[@bib101] 2013United StatesObservational65IMP12 moMean, 25 (range, 18-51)97PlateMean, 27 (range, 20-49)90Wijdicks et al,[@bib102] 2012The NetherlandsObservational90PlateMedian, 8 mo (IQR, 2-13)Mean, 39 ± 1477ESINMedian, 6 mo (IQR, 5-12)Mean, 33 ± 1670Woltz et al,[@bib103] 2017The NetherlandsRandomized trial160Sling12 moMean, 37 ± 1389PlateMean, 38 ± 1393Zehir et al,[@bib108] 2015TurkeyRandomized trial45CRxMean, 12 moMean, 33 ± 958PlateMean, 14 moMean, 32 ± 857[^1]

The studies on distal fractures were published between 2002 and 2018, and sample sizes ranged from 15 to 116 patients ([Table II](#tbl2){ref-type="table"}). The interventions compared in the studies were as follows: coracoclavicular suturing (CCSu) alone, CCSu with a locking plate (CCSu-LP), CCSu with K-wires (CCSu-KW), coracoclavicular screw fixation with an LP (CCSc-LP), a hook plate (HP), K-wires (KW) alone, a locking plate (LP) alone, tension bands with K-wires (TB-KW), and a sling. The average age of patients ranged from 34 to 51 years (median, 42 years), and the percentage of male patients ranged from 45% to 95% (median, 68%). In terms of fracture classification, patients predominantly had Neer type II fractures, with rates ranging from 60% to 100% of patients (median, 100%) across studies, but a small proportion sustained Neer type V fractures (range, 0%-40%; median, 0%). The studies provided sufficient data on function (at 3 months, 6 months, and ≥1 year of follow-up); time to radiographic union; and the risks of hardware problems, nonunion, refracture, revision, and symptoms.Table IIStudy characteristics of distal clavicle fracture studiesAuthors, yearStudy locationStudy designSample sizeInterventionsLength of follow-upAge, yrMale sex, %Chen et al,[@bib10] 2014TaiwanObservational94CC sutureMean, 38 mo (range, 24-64 mo)Mean, 43 (range, 18-75)70Hook plateMean, 37 mo (range, 24-68 mo)Mean, 48 (range, 28-78)57Erdle et al,[@bib18] 2017GermanyObservational32Hook plateMean, 54 mo (range, 25-111 mo)Mean, 44 ± 1588Locking plateMean, 44 ± 1488Flinkkila et al,[@bib22] 2002FinlandObservational39Hook plateMean, 2 yr (range, 1-2 yr)Mean, 43 (range, 18-71)94K-wireMean, 6 yr (range, 3-12 yr)Mean, 35 (range, 17-68)73Flinkkila et al,[@bib21] 2015FinlandObservational40CC sutureMean, 32 moMean, 39 ± 1495Hook plateMean, 62 moMean, 45 ± 1368Hsu et al,[@bib30] 2010TaiwanRandomized trial65Hook plate6 moMean, 43 ± 13 (range, 22-67)60TB and K-wireMean, 41 ± 14 (range, 22-67)77Hsu et al,[@bib29] 2018TaiwanObservational72CC suture12 moMean, 42 ± 1670Hook plateMean, 48 ± 2059Klein et al,[@bib39] 2010United StatesObservational38CC suture and locking plateMean, 12 mo (range, 2-47 mo)Mean, 4361Hook plateMean, 43Lee et al,[@bib45] 2009TaiwanObservational66Hook plateMean, 26 mo (range, 12-64 mo)Mean, 43 (range, 18-70)56TB and K-wireMean, 36 (range, 18-70)45Leu et al,[@bib48] 2012TaiwanObservational45Hook plateMean, 15 mo (range, 12-25 mo)Mean, 41 ± 1852TB and K-wireMean, 41 ± 1450Rokito et al,[@bib69] 2003United StatesObservational30SlingMean, 54 mo (range, 30-90 mo)Mean, 47 (range, 26-68)63CC sutureMean, 60 mo (range, 12-107 mo)Mean, 36 (range, 22-47)57Seyhan et al,[@bib74] 2015TurkeyObservational36CC suture and locking plate24 moMean, 38 (range, 20-55)71CC screw and locking plateMean, 36 (range, 34-41)75TB and K-wireMean, 34 (range, 26-44)60Souza Vilela et al,[@bib82] 2015BrazilObservational15CC suture and K-wireTwo different sets of values reported:\
Mean, 23 mo (range, 14-32 mo)\
Mean, 27 mo (range, 18-36 mo)Mean, 34 (range, 19-57)69Locking plateMean, 34 (range, 19-57)Tan et al,[@bib85] 2012ChinaObservational42Hook plateMean, 22 mo (range, 12-48 mo)Mean, 42 ± 11 (range, 21-65)65Locking plateMean, 22 mo (range, 12-48 mo)Mean, 40 ± 10 (range, 22-61)68Tang et al,[@bib86] 2018ChinaObservational40CC suture and locking plateMean, 16 mo (range, 12-27 mo)Mean, 43 ± 6NRLocking plateMean, 43 ± 5Tsuei et al,[@bib90] 2010TaiwanRandomized trial29K-wireMean, 45 mo (range, 10-85 mo)Mean, 39 ± 15 (range, 23-56)64TB and K-wireMean, 39 ± 14 (range, 21-61)73Wu et al,[@bib104] 2011TaiwanObservational116Hook plateMean, 23 moMean, 49 ± 1660TB and K-wireMean, 26 moMean, 51 ± 1871Xiong et al,[@bib106] 2018ChinaObservational58CC sutureMean, 57 mo (range, 7-160 mo)Mean, 42 ± 14NRHook plateMean, 47 ± 16Locking plateMean, 38 ± 15Yan et al,[@bib107] 2017ChinaRandomized trial72CC suture24 moMean, 38 (range, 20-55)71Hook plateMean, 35 (range, 21-56)67[^2]

The studies on medial fractures were published between 2004 and 2019 ([Table III](#tbl3){ref-type="table"}). The interventions were as follows: plating, tension bands (TB), KW, a screw and sutures, and a sling. Across the case reports, the age of patients ranged from 17 to 63 years, and among the remaining studies, the mean age ranged from 34 to 56 years. The patients were predominantly men, as the subjects of 5 of the 6 case reports were men and, across the remaining studies, the proportion of men ranged from 64% to 100%. The outcomes reported on were pain and function, radiographic union, return to prior activities, and various complications.Table IIIStudy characteristics of medial clavicle fracture studiesAuthors, yearStudy locationStudy designSample sizeInterventionsLength of follow-upAge, yrMale sex, %Bartonicek et al,[@bib5] 2010Czech RepublicCase series4Tension band, slingRange, 12-24 moMean, 45100Bourghli and Fabre,[@bib8] 2012FranceCase report1K-wires8 mo29100Frima et al,[@bib23] 2018SwitzerlandCase series15Locking plateMean, 39 mo (range, 9-79 mo)Mean, 52100Li et al,[@bib49] 2019ChinaCase report1Locking plate6 mo56100Low et al,[@bib51] 2008AustraliaCase series4Locking plate, screw and suturesMean, 3 yr (range, 8 mo to 10 yr)Mean, 43100Oe et al,[@bib63] 2012GermanyCase series9Locking plateMean, 38 mo (range, 14-52 mo)Mean, 3689Robinson et al,[@bib67] 2004United KingdomCase series24Sling24 wkMedian, 5267Siebenlist et al,[@bib76] 2013GermanyCase report1Locking plate1 yr63100Singh et al,[@bib78] 2012United KingdomObservational cohort4SlingRange, 12-28 moNRNRSmelt et al,[@bib81] 2017United KingdomCase report1Locking plate2 wk17100Teng and Liu,[@bib88] 2013TaiwanCase report1Locking plate4 yr290Titchener et al,[@bib89] 2019United KingdomCase series7Locking plateMedian, 31 mo (range, 24-45 mo)Mean, 3486Van Tongel et al,[@bib95] 2018BelgiumObservational cohort55SlingMean, 49 mo (range, 6-101 mo)Mean, 5664Wang et al,[@bib99] 2015ChinaCase report1Locking plate12 mo40100Xie et al,[@bib105] 2018ChinaCase series6Locking plateMean, 12 mo (range, 10-14 mo)Mean, 4683Zheng et al,[@bib109] 2018ChinaCase series12Locking plateMean, 23 mo (range, 12-30 mo)Mean, 4483[^3]

Outcomes {#sec2.3}
--------

### Midshaft fractures {#sec2.3.1}

#### Pain {#sec2.3.1.1}

No statistically significant differences in pain were found between treatments at any follow-up visit. In terms of effect estimates, plating was ranked highest at ≤4, 6, and 12 weeks whereas the ESIN was highest at 24, 52, and \>52 weeks ([Table IV](#tbl4){ref-type="table"}, [Supplementary Fig. S1](#appsec1){ref-type="sec"}).Table IVEffect estimates of all pair-wise comparisons for midshaft clavicle fracturesOutcomeComparisonMD or RR \[95% CrI\]Pain score (0-100) at ≤4 wkESIN vs. F8BMD, 0.61 \[−11.75 to 12.77\]ESIN vs. plateMD, 9.49 \[−2.53 to 21.63\]ESIN vs. slingMD, 2.09 \[−11.99 to 16.18\]F8B vs. plateMD, 8.91 \[−1.09 to 18.86\]F8B vs. slingMD, 1.45 \[−7.85 to 11.33\]Plate vs. slingMD, −7.42 \[−17.4 to 3.17\]Pain score (0-100) at 6 wkESIN vs. F8BMD, −9.18 \[−42.54 to 24.17\]ESIN vs. plateMD, 3.07 \[−30.08 to 36.55\]ESIN vs. slingMD, 3.14 \[−46.86 to 52.71\]F8B vs. plateMD, 12.36 \[−8.65 to 33.27\]F8B vs. slingMD, 12.31 \[−30.14 to 54.83\]Plate vs. slingMD, 0.05 \[−36.96 to 36.81\]Pain score (0-100) at 12 wkESIN vs. F8BMD, −1.04 \[−25.69 to 23.38\]ESIN vs. plateMD, 6.03 \[−18.98 to 30.30\]ESIN vs. slingMD, 4.67 \[−25.81 to 34.93\]F8B vs. plateMD, 7.09 \[−7.63 to 21.26\]F8B vs. slingMD, 5.71 \[−14.61 to 26.08\]Plate vs. slingMD, −1.32 \[−21.51 to 18.99\]Pain score (0-100) at 24 wkESIN vs. F8BMD, −5.60 \[−20.91 to 9.60\]ESIN vs. plateMD, −1.46 \[−16.74 to 13.55\]F8B vs. plateMD, 4.14 \[−5.03 to 13.16\]Pain score (0-100) at 52 wkESIN vs. F8BMD, −2.78 \[−10.79 to 5.34\]ESIN vs. plateMD, −3.29 \[−11.24 to 4.88\]ESIN vs. slingMD, −7.26 \[−18.80 to 4.32\]F8B vs. plateMD, −0.51 \[−5.25 to 4.23\]F8B vs. slingMD, −4.49 \[−14.19 to 5.22\]Plate vs. slingMD, −3.95 \[−12.41 to 4.52\]Pain score (0-100) at \>52 wkESIN vs. plateMD, −9.98 \[−23.86 to 4.04\]ESIN vs. slingMD, −7.96 \[−26.96 to 10.83\]Plate vs. slingMD, 2.00 \[−11.11 to 14.97\]Function score (0-100) at ≤4 wkESIN vs. F8BMD, 5.40 \[−23.72 to 34.69\]ESIN vs. IMPMD, 15.17 \[−30.04 to 60.34\]ESIN vs. plateMD, −2.72 \[−24.36 to 20.11\]ESIN vs. slingMD, 28.63 \[−2.71 to 60.30\]F8B vs. IMPMD, 9.70 \[−44.29 to 63.45\]F8B vs. plateMD, −8.04 \[−36.92 to 21.63\]F8B vs. slingMD, 23.21 \[−20.15 to 66.15\]IMP vs. plateMD, −17.86 \[−67.07 to 32.03\]IMP vs. slingMD, 13.39 \[−19.27 to 46.33\]Plate vs. slingMD, 31.33 \[−7.71 to 69.54\]Function score (0-100) at 6 wkCRx vs. ESINMD, 9.46 \[−12.59 to 30.83\]CRx vs. F8BMD, 17.05 \[−7.41 to 41.30\]CRx vs. F8B + slingMD, 17.93 \[−7.07 to 42.87\]CRx vs. IMPMD, 10.36 \[−20.38 to 40.70\]CRx vs. plateMD, 11.04 \[−9.78 to 31.58 \]CRx vs. slingMD, 20.16 \[−1.61 to 42.08\]ESIN vs. F8BMD, 7.67 \[−6.13 to 21.53\]ESIN vs. F8B + slingMD, 8.54 \[−7.37 to 24.26\]ESIN vs. IMPMD, 0.87 \[−22.86 to 24.60\]ESIN vs. plateMD, 1.60 \[−5.31 to 8.51\]ESIN vs. sling[∗](#tbl4fnlowast){ref-type="table-fn"}MD, 10.73 \[1.21 to 20.35\]F8B vs. F8B + slingMD, 0.90 \[−18.47 to 20.27\]F8B vs. IMPMD, −6.72 \[−32.91 to 19.45\]F8B vs. plateMD, −6.07 \[−19.06 to 7.05\]F8B vs. slingMD, 3.09 \[−11.74 to 17.99\]F8B + sling vs. IMPMD, −7.54 \[−34.40 to 19.18\]F8B + sling vs. plateMD, −6.91 \[−21.04 to 7.39\]F8B + sling vs. slingMD, 2.23 \[−13.68 to 18.32\]IMP vs. plateMD, 0.69 \[−22.26 to 23.48\]IMP vs. slingMD, 9.79 \[−11.73 to 31.50\]Plate vs. sling[∗](#tbl4fnlowast){ref-type="table-fn"}MD, 9.12 \[1.66 to 16.66\]Function score (0-100) at 12 wkCRx vs. ESINMD, 7.88 \[−5.32 to 21.12\]CRx vs. F8B[∗](#tbl4fnlowast){ref-type="table-fn"}MD, 14.89 \[0.22 to 29.65\]CRx vs. F8B + sling[∗](#tbl4fnlowast){ref-type="table-fn"}MD, 17.86 \[1.07 to 34.49\]CRx vs. IMPMD, 5.16 \[−16.23 to 26.52\]CRx vs. plateMD, 9.98 \[−2.42 to 22.53\]CRx vs. slingMD, 12.88 \[−0.16 to 26.24\]ESIN vs. F8BMD, 7.07 \[−1.27 to 15.43\]ESIN vs. F8B + slingMD, 9.96 \[−1.83 to 21.96\]ESIN vs. IMPMD, −2.66 \[−20.27 to 15.17\]ESIN vs. plateMD, 2.12 \[−2.25 to 6.65\]ESIN vs. slingMD, 5.03 \[−0.49 to 10.74\]F8B vs. F8B + slingMD, 2.92 \[−10.79 to 16.62\]F8B vs. IMPMD, −9.74 \[−28.31 to 8.90\]F8B vs. plateMD, −4.95 \[−12.88 to 3.11\]F8B vs. slingMD, −2.03 \[−9.98 to 5.98\]F8B + sling vs. IMPMD, −12.63 \[−33.22 to 7.97\]F8B + sling vs. plateMD, −7.82 \[−18.99 to 3.37\]F8B + sling vs. slingMD, −4.90 \[−16.65 to 6.84\]IMP vs. plateMD, 4.79 \[−12.59 to 22.03\]IMP vs. slingMD, 7.69 \[−9.03 to 24.55\]Plate vs. slingMD, 2.91 \[−1.16 to 7.01\]Function score (0-100) at 24 wkCRx vs. ESINMD, 8.01 \[−1.56 to 17.68\]CRx vs. F8B[∗](#tbl4fnlowast){ref-type="table-fn"}MD, 14.65 \[4.70 to 24.79\]CRx vs. F8B + sling[∗](#tbl4fnlowast){ref-type="table-fn"}MD, 13.39 \[2.04 to 24.53\]CRx vs. IMP[∗](#tbl4fnlowast){ref-type="table-fn"}MD, 12.18 \[1.16 to 23.34\]CRx vs. plate[∗](#tbl4fnlowast){ref-type="table-fn"}MD, 9.99 \[0.87 to 19.27\]CRx vs. sling[∗](#tbl4fnlowast){ref-type="table-fn"}MD, 14.59 \[4.97 to 24.49\]ESIN vs. F8B[∗](#tbl4fnlowast){ref-type="table-fn"}MD, 6.65 \[1.90 to 11.39\]ESIN vs. F8B + slingMD, 5.35 \[−1.74 to 12.25\]ESIN vs. IMPMD, 4.13 \[−2.53 to 10.96\]ESIN vs. plateMD, 1.97 \[−0.81 to 4.79\]ESIN vs. sling[∗](#tbl4fnlowast){ref-type="table-fn"}MD, 6.58 \[2.60 to 10.65\]F8B vs. F8B + slingMD, −1.30 \[−9.04 to 6.16\]F8B vs. IMPMD, −2.54 \[−9.93 to 4.96\]F8B vs. plate[∗](#tbl4fnlowast){ref-type="table-fn"}MD, −4.68 \[−8.75 to −0.57\]F8B vs. slingMD, −0.09 \[−5.19 to 5.14\]F8B + sling vs. IMPMD, −1.23 \[−10.03 to 7.92\]F8B + sling vs. plateMD, −3.37 \[−9.63 to 3.24\]F8B + sling vs. slingMD, 1.22 \[−5.77 to 8.52\]IMP vs. plateMD, −2.14 \[−8.40 to 4.00\]IMP vs. slingMD, 2.47 \[−3.93 to 8.84\]Plate vs. sling[∗](#tbl4fnlowast){ref-type="table-fn"}MD, 4.60 \[1.45 to 7.86\]Function score (0-100) at 52 wkCRx vs. ESINMD, 2.53 \[−3.42 to 8.43\]CRx vs. F8BMD, 4.27 \[−2.62 to 11.20\]CRx vs. IMPMD, 3.52 \[−3.48 to 10.63\]CRx vs. plateMD, 2.84 \[−2.01 to 7.70\]CRx vs. sling[∗](#tbl4fnlowast){ref-type="table-fn"}MD, 5.82 \[0.31 to 11.47\]ESIN vs. F8BMD, 1.72 \[−3.81 to 7.37\]ESIN vs. IMPMD, 0.99 \[−5.07 to 7.08\]ESIN vs. plateMD, 0.28 \[−3.00 to 3.74\]ESIN vs. slingMD, 3.29 \[−0.87 to 7.67\]F8B vs. IMPMD, −0.72 \[−7.68 to 6.28\]F8B vs. plateMD, −1.42 \[−6.36 to 3.55\]F8B vs. slingMD, 1.56 \[−3.55 to 6.85\]IMP vs. plateMD, −0.70 \[−5.72 to 4.34\]IMP vs. slingMD, 2.30 \[−2.89 to 7.61\]Plate vs. sling[∗](#tbl4fnlowast){ref-type="table-fn"}MD, 3.00 \[0.33 to 5.73\]Function score (0-100) at \>52 wkESIN vs. F8BMD, 0.98 \[−12.32 to 14.47\]ESIN vs. IMPMD, −0.85 \[−9.71 to 8.16\]ESIN vs. plateMD, 0.11 \[−2.43 to 2.92\]ESIN vs. sling[∗](#tbl4fnlowast){ref-type="table-fn"}MD, 4.75 \[1.56 to 8.04\]F8B vs. IMPMD, −1.85 \[−11.78 to 8.15\]F8B vs. plateMD, −0.82 \[−14.06 to 12.27\]F8B vs. slingMD, 3.81 \[−9.82 to 17.15\]IMP vs. plateMD, 0.99 \[−7.46 to 9.57\]IMP vs. slingMD, 5.63 \[−3.47 to 14.56\]Plate vs. sling[∗](#tbl4fnlowast){ref-type="table-fn"}MD, 4.63 \[1.56 to 7.54\]Time to radiographic union, wkCRx vs. ESINMD, −4.50 \[−10.33 to 1.61\]CRx vs. F8B[∗](#tbl4fnlowast){ref-type="table-fn"}MD, −10.44 \[−19.73 to −1.04\]CRx vs. IMPMD, −4.73 \[−12.23 to 2.78\]CRx vs. plateMD, −5.38 \[−10.73 to 0.00\]CRx vs. sling[∗](#tbl4fnlowast){ref-type="table-fn"}MD, −11.37 \[−17.79 to −4.73\]ESIN vs. F8BMD, −5.96 \[−14.21 to 1.94\]ESIN vs. IMPMD, −0.24 \[−6.32 to 5.51\]ESIN vs. plateMD, −0.89 \[−3.63 to 1.63\]ESIN vs. sling[∗](#tbl4fnlowast){ref-type="table-fn"}MD, −6.88 \[−10.55 to −3.27\]F8B vs. IMPMD, 5.70 \[−3.50 to 14.86\]F8B vs. plateMD, 5.08 \[−2.54 to 12.69\]F8B vs. slingMD, −0.91 \[−9.22 to 7.71\]IMP vs. plateMD, −0.63 \[−5.89 to 4.61\]IMP vs. sling[∗](#tbl4fnlowast){ref-type="table-fn"}MD, −6.62 \[−12.93 to −0.05\]Plate vs. sling[∗](#tbl4fnlowast){ref-type="table-fn"}MD, −5.99 \[−9.67 to −2.15\]Time to return to work, wkESIN vs. F8BMD, −2.80 \[−6.16 to 0.37\]ESIN vs. plateMD, −1.30 \[−4.04 to 1.48\]ESIN vs. slingMD, −2.44 \[−5.77 to 0.76\]F8B vs. plateMD, 1.49 \[−0.64 to 3.90\]F8B vs. slingMD, 0.35 \[−2.16 to 3.00\]Plate vs. slingMD, −1.14 \[−3.10 to 0.71\]Delayed unionCRx vs. ESINRR, 1.21 \[0.00 to 473\]CRx vs. F8BRR, 1.63 \[0.00 to 1097\]CRx vs. IMPRR, 0.41 \[0.00 to 270\]CRx vs. plateRR, 2.80 \[0.02 to 523\]CRx vs. slingRR, 1.30 \[0.01 to 408\]ESIN vs. F8BRR, 1.34 \[0.03 to 183\]ESIN vs. IMPRR, 0.34 \[0.00 to 50\]ESIN vs. plateRR, 2.32 \[0.11 to 81\]ESIN vs. slingRR, 1.06 \[0.08 to 22\]F8B vs. IMPRR, 0.25 \[0.00 to 40\]F8B vs. plateRR, 1.77 \[0.03 to 50\]F8B vs. slingRR, 0.81 \[0.01 to 37\]IMP vs. plateRR, 6.82 \[0.13 to 804\]IMP vs. slingRR, 3.11 \[0.06 to 463\]Plate vs. slingRR, 0.46 \[0.04 to 5.15\]MalunionESIN vs. F8B + sling[∗](#tbl4fnlowast){ref-type="table-fn"}RR, 0.11 \[0.00 to 0.93\]ESIN vs. IMPRR, 1.09 \[0.16 to 6.30\]ESIN vs. plateRR, 2.27 \[0.84 to 6.11\]ESIN vs. slingRR, 0.59 \[0.21 to 1.65\]F8B + sling vs. IMPRR, 10 \[0.83 to 395\]F8B + sling vs. plate[∗](#tbl4fnlowast){ref-type="table-fn"}RR, 20 \[3.19 to 679\]F8B + sling vs. slingRR, 5.40 \[0.75 to 183\]IMP vs. plateRR, 2.08 \[0.46 to 11\]IMP vs. slingRR, 0.54 \[0.11 to 3.32\]Plate vs. sling[∗](#tbl4fnlowast){ref-type="table-fn"}RR, 0.26 \[0.14 to 0.49\]NonunionESIN vs. F8B[∗](#tbl4fnlowast){ref-type="table-fn"}RR, 0.26 \[0.06 to 0.91\]ESIN vs. F8B + sling[∗](#tbl4fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.13\]ESIN vs. IMPRR, 0.69 \[0.20 to 2.18\]ESIN vs. plateRR, 1.67 \[0.89 to 3.39\]ESIN vs. sling[∗](#tbl4fnlowast){ref-type="table-fn"}RR, 0.38 \[0.19 to 0.79\]F8B vs. F8B + sling[∗](#tbl4fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.51\]F8B vs. IMPRR, 2.66 \[0.63 to 13\]F8B vs. plate[∗](#tbl4fnlowast){ref-type="table-fn"}RR, 6.36 \[2.18 to 24\]F8B vs. slingRR, 1.46 \[0.46 to 5.78\]IMP vs. F8B + sling[∗](#tbl4fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.18\]Plate vs. F8B + sling[∗](#tbl4fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.08\]Sling vs. F8B + sling[∗](#tbl4fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.34\]IMP vs. plateRR, 2.41 \[0.96 to 6.89\]IMP vs. slingRR, 0.55 \[0.20 to 1.68\]Plate vs. sling[∗](#tbl4fnlowast){ref-type="table-fn"}RR, 0.23 \[0.15 to 0.35\]RefractureESIN vs. IMPRR, 1.73 \[0.13 to 32\]ESIN vs. plateRR, 1.03 \[0.23 to 5.87\]ESIN vs. slingRR, 2.77 \[0.38 to 37\]IMP vs. plateRR, 0.59 \[0.06 to 5.42\]IMP vs. slingRR, 1.60 \[0.15 to 21\]Plate vs. slingRR, 2.69 \[0.56 to 20\]RevisionESIN vs. F8BRR, 3.16 \[0.29 to 104\]ESIN vs. IMPRR, 0.17 \[0.00 to 2.44\]ESIN vs. plateRR, 1.09 \[0.37 to 3.35\]ESIN vs. slingRR, 0.83 \[0.23 to 2.90\]F8B vs. IMPRR, 0.05 \[0.00 to 1.60\]F8B vs. plateRR, 0.34 \[0.01 to 3.86\]F8B vs. slingRR, 0.26 \[0.01 to 3.07\]IMP vs. plateRR, 6.30 \[0.61 to 189\]IMP vs. slingRR, 4.72 \[0.40 to 144\]Plate vs. slingRR, 0.76 \[0.38 to 1.37\]SymptomsCRx vs. ESINRR, 0.32 \[0.00 to 58\]CRx vs. F8BRR, 0.90 \[0.00 to 245\]CRx vs. IMPRR, 0.86 \[0.00 to 118\]CRx vs. plateRR, 0.43 \[0.00 to 46\]CRx vs. slingRR, 2.04 \[0.01 to 608\]ESIN vs. F8BRR, 2.80 \[0.07 to 145\]ESIN vs. IMPRR, 2.69 \[0.17 to 46\]ESIN vs. plateRR, 1.35 \[0.13 to 14\]ESIN vs. slingRR, 6.30 \[0.22 to 372\]F8B vs. IMPRR, 0.96 \[0.04 to 20\]F8B vs. plateRR, 0.48 \[0.02 to 9.49\]F8B vs. slingRR, 2.24 \[0.05 to 193\]IMP vs. plateRR, 0.50 \[0.11 to 2.20\]IMP vs. slingRR, 2.31 \[0.13 to 85\]Plate vs. slingRR, 4.62 \[0.38 to 121\][^4][^5]

#### Function {#sec2.3.1.2}

No statistically significant differences in function were found between treatments at ≤4 weeks, although plating was ranked highest ([Table IV](#tbl4){ref-type="table"}, [Supplementary Fig. S2](#appsec1){ref-type="sec"}). For function at 6 weeks, both the ESIN and plating had significantly higher scores compared with the sling ([Table IV](#tbl4){ref-type="table"}; [Fig. 4](#fig4){ref-type="fig"}, *a*). At 12 weeks, scores were significantly higher with the CRx relative to the F8B ([Table IV](#tbl4){ref-type="table"}; [Fig. 4](#fig4){ref-type="fig"}, *b*). Function at 24 weeks was significantly lower with both the sling and F8B compared with the CRx, ESIN, and plating ([Table IV](#tbl4){ref-type="table"}; [Fig. 4](#fig4){ref-type="fig"}, *c*); the CRx also demonstrated significantly higher scores than the F8B-sling combination, IMP, and plating at this follow-up point. Both the CRx and plating showed significantly greater function than the sling at 52 weeks ([Table IV](#tbl4){ref-type="table"}; [Fig. 4](#fig4){ref-type="fig"}, *d*). At visits at \>52 weeks, both the ESIN and plating showed significantly improved function relative to the sling ([Table IV](#tbl4){ref-type="table"}; [Fig. 4](#fig4){ref-type="fig"}, *e*).Figure 4Forest plot of function at 6 weeks (**a**), 12 weeks (**b**), 24 weeks (**c**), 52 weeks (**d**), and \>52 weeks (**e**) for midshaft clavicle fractures. *CrI*, credible interval; *CRx*, Sonoma CRx intramedullary nail; *ESIN*, elastic stable intramedullary nail; *F8B*, figure-of-8 bandage; *F8B Sling*, figure-of-8 bandage with sling; *IMP*, intramedullary pin.

#### Time to radiographic union {#sec2.3.1.3}

The sling demonstrated a significantly later time to radiographic union relative to the CRx, ESIN, plating, and IMP ([Table IV](#tbl4){ref-type="table"}; [Fig. 5](#fig5){ref-type="fig"}). In addition, the CRx showed a significantly earlier time to union than the F8B.Figure 5Forest plot of time to radiographic union for midshaft clavicle fractures. *CrI*, credible interval; *CRx*, Sonoma CRx intramedullary nail; *ESIN*, elastic stable intramedullary nail; *F8B*, figure-of-8 bandage; *IMP*, intramedullary pin.

#### Time to return to work {#sec2.3.1.4}

The ESIN was ranked highest for the outcome of time to return to work, but we did not find any statistically significant differences between the ESIN, F8B, plating, and sling ([Table IV](#tbl4){ref-type="table"}, [Supplementary Fig. S3](#appsec1){ref-type="sec"}).

#### Delayed union {#sec2.3.1.5}

For delayed union, none of the pair-wise comparisons in this analysis were statistically significant, but plating was ranked highest ([Table IV](#tbl4){ref-type="table"}, [Supplementary Fig. S4](#appsec1){ref-type="sec"}).

#### Malunion {#sec2.3.1.6}

Plating demonstrated a significantly lower risk of malunion compared with both the sling and F8B-sling combination, whereas the ESIN had a significantly lower risk relative to the F8B-sling combination only ([Table IV](#tbl4){ref-type="table"}, [Fig. 6](#fig6){ref-type="fig"}).Figure 6Forest plot of malunion for midshaft clavicle fractures. *CrI*, credible interval; *ESIN*, elastic stable intramedullary nail; *F8B Sling*, figure-of-8 bandage with sling; *IMP*, intramedullary pin.

#### Nonunion {#sec2.3.1.7}

Both plating and the ESIN showed a significantly reduced risk of nonunion compared with the sling, F8B, and F8B-sling combination ([Table IV](#tbl4){ref-type="table"}, [Fig. 7](#fig7){ref-type="fig"}); plating was ranked highest. The IMP, sling alone, and F8B alone all had a significantly lower risk relative to the F8B-sling combination.Figure 7Forest plot of nonunion for midshaft clavicle fractures. *CrI*, credible interval; *ESIN*, elastic stable intramedullary nail; *F8B*, figure-of-8 bandage; *F8B Sling*, figure-of-8 bandage with sling; *IMP*, intramedullary pin.

#### Refracture {#sec2.3.1.8}

We found no significant differences between the ESIN, IMP, plating, and sling for the incidence of refracture ([Table IV](#tbl4){ref-type="table"}, [Supplementary Fig. S5](#appsec1){ref-type="sec"}).

#### Revision {#sec2.3.1.9}

There were no statistically significant differences between the ESIN, F8B, IMP, and plating in the risk of revision ([Table IV](#tbl4){ref-type="table"}, [Supplementary Fig. S6](#appsec1){ref-type="sec"}).

#### Symptoms {#sec2.3.1.10}

In terms of persistent symptoms following treatment, no statistically significant differences were found between the CRx, ESIN, F8B, IMP, plating, and sling ([Table IV](#tbl4){ref-type="table"}, [Supplementary Fig. S7](#appsec1){ref-type="sec"}).

### Distal fractures {#sec2.3.2}

#### Function {#sec2.3.2.1}

We found no statistically significant results between interventions in functional scores at 3 months ([Table V](#tbl5){ref-type="table"}, [Supplementary Fig. S8](#appsec1){ref-type="sec"}). CCSu was ranked highest, followed by the HP, CCSu-LP, LP, TB-KW, and finally, CCSc-LP.Table VEffect estimates of all pair-wise comparisons for distal clavicle fracturesOutcomeComparisonMD or RR \[95% CrI\]Function score (0-100) at 3 moCCSc-LP vs. CCSuMD, −17.08 \[−40.91 to 6.50\]CCSc-LP vs. CCSu-LPMD, −10.00 \[−23.05 to 2.90\]CCSc-LP vs. HPMD, −12.03 \[−31.93 to 8.05\]CCSc-LP vs. LPMD, −9.33 \[−27.77 to 9.04\]CCSc-LP vs. TB-KWMD, −5.60 \[−19.25 to 8.05\]CCSu vs. CCSu-LPMD, 7.04 \[−16.60 to 30.85\]CCSu vs. HPMD, 5.11 \[−7.67 to 17.91\]CCSu vs. LPMD, 7.71 \[−19.13 to 34.49\]CCSu vs. TB-KWMD, 11.50 \[−7.82 to 30.75\]CCSu-LP vs. HPMD, −1.99 \[−21.90 to 17.80\]CCSu-LP vs. LPMD, 0.66 \[−12.30 to 13.56\]CCSu-LP vs. TB-KWMD, 4.39 \[−9.25 to 18.02\]HP vs. LPMD, 2.65 \[−20.93 to 26.38\]HP vs. TB-KWMD, 6.40 \[−8.04 to 20.75\]LP vs. TB-KWMD, 3.72 \[−15.07 to 22.30\]Function score (0-100) at 6 moCCSc-LP vs. CCSuMD, −8.14 \[−22.79 to 6.63\]CCSc-LP vs. CCSu-LPMD, −3.69 \[−11.43 to 4.07\]CCSc-LP vs. HPMD, −4.51 \[−17.27 to 8.09\]CCSc-LP vs. TB-KWMD, 1.01 \[−7.95 to 9.91\]CCSu vs. CCSu-LPMD, 4.48 \[−10.29 to 19.00\]CCSu vs. HPMD, 3.70 \[−3.77 to 11.19\]CCSu vs. TB-KWMD, 9.15 \[−2.42 to 20.70\]CCSu-LP vs. HPMD, −0.76 \[−13.46 to 11.85\]CCSu-LP vs. TB-KWMD, 4.69 \[−4.25 to 13.70\]HP vs. TB-KWMD, 5.47 \[−3.49 to 14.36\]Function score (0-100) at ≥1 yrCCSc-LP vs. CCSuMD, −3.09 \[−12.00 to 5.57\]CCSc-LP vs. CCSu-KWMD, 2.13 \[−10.47 to 14.45\]CCSc-LP vs. CCSu-LPMD, −4.42 \[−11.57 to 2.44\]CCSc-LP vs. HPMD, 0.15 \[−7.83 to 8.09\]CCSc-LP vs. KWMD, 6.91 \[−2.65 to 16.58\]CCSc-LP vs. LPMD, −4.92 \[−13.41 to 3.41\]CCSc-LP vs. TB-KWMD, 1.45 \[−6.13 to 8.70\]CCSu vs. CCSu-KWMD, 5.22 \[−5.83 to 16.34\]CCSu vs. CCSu-LPMD, −1.37 \[−8.69 to 6.01\]CCSu vs. HPMD, 3.22 \[−0.55 to 7.20\]CCSu vs. KW[∗](#tbl5fnlowast){ref-type="table-fn"}MD, 9.98 \[2.86 to 17.52\]CCSu vs. LPMD, −1.78 \[−8.35 to 4.68\]CCSu vs. TB-KWMD, 4.52 \[−1.05 to 10.10\]CCSu-KW vs. CCSu-LPMD, −6.61 \[−17.63 to 4.25\]CCSu-KW vs. HPMD, −1.99 \[−12.37 to 8.52\]CCSu-KW vs. KWMD, 4.75 \[−7.10 to 17.00\]CCSu-KW vs. LPMD, −7.03 \[−16.11 to 1.90\]CCSu-KW vs. TB-KWMD, −0.72 \[−11.64 to 10.23\]CCSu-LP vs. HPMD, 4.60 \[−1.51 to 10.83\]CCSu-LP vs. KW[∗](#tbl5fnlowast){ref-type="table-fn"}MD, 11.36 \[3.11 to 19.84\]CCSu-LP vs. LPMD, −0.44 \[−6.61 to 5.65\]CCSu-LP vs. TB-KWMD, 5.89 \[−0.19 to 11.97\]HP vs. KW[∗](#tbl5fnlowast){ref-type="table-fn"}MD, 6.74 \[0.58 to 13.06\]HP vs. LPMD, −5.04 \[−10.41 to 0.13\]HP vs. TB-KWMD, 1.32 \[−2.84 to 5.14\]KW vs. LP[∗](#tbl5fnlowast){ref-type="table-fn"}MD, −11.80 \[−20.02 to −3.95\]KW vs. TB-KWMD, −5.45 \[−12.11 to 0.95\]LP vs. TB-KW[∗](#tbl5fnlowast){ref-type="table-fn"}MD, 6.36 \[0.26 to 12.49\]Time to radiographic union, wkCCSc-LP vs. CCSuMD, −7.57 \[−27.81 to 12.10\]CCSc-LP vs. CCSu-LPMD, 3.37 \[−8.06 to 14.90\]CCSc-LP vs. HPMD, −3.75 \[−20.40 to 12.78\]CCSc-LP vs. KWMD, −3.94 \[−20.40 to 12.48\]CCSc-LP vs. LPMD, −4.53 \[−24.85 to 12.72\]CCSc-LP vs. TB-KWMD, −3.34 \[−15.76 to 9.03\]CCSu vs. CCSu-LPMD, 10.93 \[−8.75 to 31.22\]CCSu vs. HPMD, 3.82 \[−7.16 to 14.76\]CCSu vs. KWMD, 3.61 \[−15.39 to 22.86\]CCSu vs. LPMD, 3.27 \[−12.59 to 15.56\]CCSu vs. TB-KWMD, 4.26 \[−11.30 to 19.90\]CCSu-LP vs. HPMD, −7.09 \[−23.77 to 9.37\]CCSu-LP vs. KWMD, −7.28 \[−23.67 to 9.13\]CCSu-LP vs. LPMD, −7.86 \[−28.23 to 9.75\]CCSu-LP vs. TB-KWMD, −6.67 \[−18.90 to 5.60\]HP vs. KWMD, −0.16 \[−15.58 to 15.25\]HP vs. LPMD, −0.52 \[−11.23 to 6.73\]HP vs. TB-KWMD, 0.45 \[−10.65 to 11.36\]KW vs. LPMD, −0.36 \[−19.96 to 15.57\]KW vs. TB-KWMD, 0.61 \[−10.44 to 11.35\]LP vs. TB-KWMD, 1.00 \[−11.49 to 16.90\]Hardware complicationsCCSu vs. CCSu-LPRR, 1.43 \[0.00 to 523\]CCSu vs. HPRR, 2.03 \[0.02 to 217\]CCSu vs. KWRR, 0.10 \[0.00 to 24\]CCSu vs. LPRR, 1.45 \[0.00 to 545\]CCSu vs. TB-KWRR, 0.73 \[0.00 to 145\]CCSu-LP vs. HPRR, 1.40 \[0.04 to 59\]CCSu-LP vs. KWRR, 0.07 \[0.00 to 7.77\]CCSu-LP vs. LPRR, 1.03 \[0.03 to 39\]CCSu-LP vs. TB-KWRR, 0.50 \[0.01 to 43\]HP vs. KW[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.05 \[0.00 to 0.93\]HP vs. LPRR, 0.72 \[0.02 to 29\]HP vs. TB-KWRR, 0.35 \[0.05 to 3.71\]KW vs. LPRR, 14 \[0.13 to 1510\]KW vs. TB-KWRR, 6.69 \[0.48 to 179\]LP vs. TB-KWRR, 0.49 \[0.01 to 41\]NonunionCCSc-LP vs. CCSuRR, 0.76 \[0.01 to 68\]CCSu-LP vs. CCSc-LP[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.97\]CCSc-LP vs. HPRR, 2.05 \[0.03 to 156\]CCSc-LP vs. KWRR, 4.06 \[0.03 to 608\]LP vs. CCSc-LP[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.51\]CCSc-LP vs. TB-KWRR, 0.84 \[0.02 to 44\]CCSu-LP vs. CCSu[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.90\]CCSu vs. HPRR, 2.66 \[0.64 to 15\]CCSu vs. KWRR, 5.26 \[0.35 to 120\]LP vs. CCSu[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.14\]CCSu vs. TB-KWRR, 1.12 \[0.10 to 15\]CCSu-LP vs. HPRR, 0.00 \[0.00 to 2.32\]CCSu-LP vs. KWRR, 0.00 \[0.00 to 6.23\]CCSu-LP vs. LPRR, 6.36 \[0.00 to 2.29 × 10^20^\]CCSu-LP vs. TB-KW[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.77\]HP vs. KWRR, 1.95 \[0.19 to 26\]LP vs. HP[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.09\]HP vs. TB-KWRR, 0.42 \[0.06 to 10\]LP vs. KW[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.93\]KW vs. TB-KWRR, 0.21 \[0.01 to 4.48\]LP vs. TB-KW[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.19\]RefractureCCSu vs. CCSu-LPRR, 2.44 \[0.08 to 144\]CCSu vs. HPRR, 0.76 \[0.13 to 4.10\]KW vs. CCSu[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.85\]LP vs. CCSu[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.52\]TB-KW vs. CCSu[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.00\]CCSu-LP vs. HPRR, 0.32 \[0.01 to 5.53\]KW vs. CCSu-LPRR, 0.00 \[0.00 to 4.26\]LP vs. CCSu-LPRR, 0.00 \[0.00 to 1.82\]TB-KW vs. CCSu-LP[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.00\]KW vs. HP[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.57\]LP vs. HP[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.34\]TB-KW vs. HP[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.00\]LP vs. KWRR, 0.00 \[0.00 to 9.55 × 10^9^\]TB-KW vs. KW[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.38\]TB-KW vs. LPRR, 0.00 \[0.00 to 1.07 × 10^15^\]RevisionCCSu vs. CCSc-LPRR, 0.07 \[0.00 to 40\]CCSu-LP vs. CCSc-LP[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.01\]HP vs. CCSc-LPRR, 0.08 \[0.00 to 25\]KW vs. CCSc-LPRR, 0.11 \[0.00 to 116\]TB-KW vs. CCSc-LPRR, 0.31 \[0.01 to 13\]CCSu-LP vs. CCSu[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.45\]CCSu vs. HPRR, 0.85 \[0.04 to 14\]CCSu vs. KWRR, 0.64 \[0.00 to 91\]CCSu vs. TB-KWRR, 0.23 \[0.00 to 38\]CCSu-LP vs. HP[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.28\]CCSu-LP vs. KW[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.28\]CCSu-LP vs. TB-KW[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.05\]HP vs. KWRR, 0.76 \[0.01 to 45\]HP vs. TB-KWRR, 0.28 \[0.00 to 21\]KW vs. TB-KWRR, 0.36 \[0.00 to 130\]SymptomsCCSc-LP vs. CCSu[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.18\]CCSu-LP vs. CCSc-LP[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.01\]CCSc-LP vs. HPRR, 4.26 \[0.12 to 198\]CCSc-LP vs. TB-KWRR, 1.80 \[0.10 to 39\]CCSu-LP vs. CCSu[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.00\]HP vs. CCSu[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.03\]TB-KW vs. CCSu[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.08\]CCSu-LP vs. HP[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.07\]CCSu-LP vs. TB-KW[∗](#tbl5fnlowast){ref-type="table-fn"}RR, 0.00 \[0.00 to 0.03\]HP vs. TB-KWRR, 0.42 \[0.05 to 3.32\][^6][^7]

For function at 6 months, we found no statistically significant differences between interventions ([Table V](#tbl5){ref-type="table"}, [Supplementary Fig. S8](#appsec1){ref-type="sec"}). CCSu was again ranked highest, followed by CCSu-LP, the HP, CCSc-LP, and TB-KW.

For function at follow-up ≥ 1 year, we noted statistically significant findings between some of the pair-wise comparisons ([Table V](#tbl5){ref-type="table"}, [Fig. 8](#fig8){ref-type="fig"}). KW demonstrated significantly worse outcomes than CCSu, CCSu-LP, the HP, and the LP; the LP was also significantly better than TB-KW. The corresponding SUCRA values were 87% for the LP, 83% for CCSu-LP, 73% for CCSu, 45% for CCSc-LP, 43% for the HP, 32% for CCSu-KW, 31% for TB-KW, and 5% for KW.Figure 8Forest plot of function at ≥1 year for distal clavicle fractures. *CrI*, credible interval; *CCSu*, coracoclavicular suturing; *CCSc*, coracoclavicular screw fixation; *LP*, locking plate; *KW*, K-wires; *HP*, hook plate; *TB*, tension band.

#### Time to radiographic union {#sec2.3.2.2}

We did not find any significant differences in the time to radiographic union between treatments ([Table V](#tbl5){ref-type="table"}, [Supplementary Fig. S9](#appsec1){ref-type="sec"}). CCSu-LP was ranked highest for this outcome, followed by CCSc-LP, TB-KW, the HP, KW, the LP, and finally, CCSu.

#### Hardware complications {#sec2.3.2.3}

There was 1 statistically significant comparison, demonstrating that KW resulted in a greater risk of hardware complications than the HP ([Table V](#tbl5){ref-type="table"}, [Fig. 9](#fig9){ref-type="fig"}). The corresponding SUCRA values were 73% for the HP, 60% for the LP, 60% for CCSu-LP, 53% for CCSu, 45% for TB-KW, and 10% for KW.Figure 9Forest plot of hardware complications for distal clavicle fractures. *CrI*, credible interval; *CCSu*, coracoclavicular suturing; *LP*, locking plate; *HP*, hook plate; *KW*, K-wires; *TB*, tension band.

#### Nonunion {#sec2.3.2.4}

Both the LP and CCSu-LP had significantly lower risks of nonunion compared with each of the following: CCSc-LP, TB-KW, HP, CCSu, and sling ([Table V](#tbl5){ref-type="table"}, [Fig. 10](#fig10){ref-type="fig"}). Only the LP showed a significantly lower risk of this event relative to KW. The LP and CCSu-LP had the highest SUCRA values, at 91% and 88%, respectively, followed by KW (55%), the HP (45%), CCSc-LP (30%), TB-KW (22%), and finally, CCSu (19%).Figure 10Forest plot of nonunion for distal clavicle fractures. *CrI*, credible interval; *CCSu*, coracoclavicular suturing; *CCSc*, coracoclavicular screw fixation; *LP*, locking plate; *HP*, hook plate; *KW*, K-wires; *TB*, tension band.

#### Refracture {#sec2.3.2.5}

TB-KW demonstrated a significantly lower risk of refracture compared with CCSu, CCSu-LP, the HP, and KW; both the LP and KW had significantly lower risks relative to CCSu and the HP ([Table V](#tbl5){ref-type="table"}, [Fig. 11](#fig11){ref-type="fig"}). The SUCRA values were 94% for TB-KW, 77% for the LP, 65% for KW, 32% for CCSu-LP, 19% for CCSu, and 12% for the HP.Figure 11Forest plot of refracture for distal clavicle fractures. *CrI*, credible interval; *CCSu*, coracoclavicular suturing; *LP*, locking plate; *HP*, hook plate; *KW*, K-wires; *TB*, tension band.

#### Revision {#sec2.3.2.6}

Regarding the risk of revision, CCSu-LP demonstrated a significantly lower risk than all other interventions included in the analysis ([Table V](#tbl5){ref-type="table"}, [Fig. 12](#fig12){ref-type="fig"}). The SUCRA values were 99% for CCSu-LP, 55% for CCSu, 52% for the HP, 46% for KW, 33% for TB-KW, and 14% for CCSc-LP.Figure 12Forest plot of revision for distal clavicle fractures. *CrI*, credible interval; *CCSu*, coracoclavicular suturing; *CCSc*, coracoclavicular screw fixation; *LP*, locking plate; *HP*, hook plate; *KW*, K-wires; *TB*, tension band.

#### Symptoms {#sec2.3.2.7}

In the analysis of persistent symptoms, CCSu-LP showed a significantly lower risk than CCSc-LP, CCSu, the HP, and TB-KW; CCSc-LP, the HP, and TB-KW each had a significantly lower risk compared with CCSu only ([Table V](#tbl5){ref-type="table"}, [Fig. 13](#fig13){ref-type="fig"}). The corresponding SUCRA values were 99% for CCSu-LP, 69% for the HP, 47% for TB-KW, 33% for CCSc-LP, and 0.3% for CCSu.Figure 13Forest plot of symptoms for distal clavicle fractures. *CrI*, credible interval; *CCSu*, coracoclavicular suturing; *CCSc*, coracoclavicular screw fixation; *LP*, locking plate; *HP*, hook plate; *TB*, tension band; *KW*, K-wires.

### Medial fractures {#sec2.3.3}

Across all studies on patients with medial fractures, 85 patients were managed with a sling, 57 were treated with plating, 2 received TB, 1 was treated with KW, and 1 received a screw and suturing.

#### Pain {#sec2.3.3.1}

The visual analog scale (VAS) scores for pain on activity following nonoperative therapy in the study by Bartonicek et al[@bib5] were 1 of 10 for 1 patient and 2 of 10 for the other patient at 18 and 13 months, respectively. Regarding plating, in the case reports by Li et al[@bib49], [@bib81], [@bib88] and Smelt et al[@bib49], [@bib81], [@bib88], the patients reported no pain at 2 and 8 weeks, respectively, whereas the patient in the report by Teng and Liu[@bib49], [@bib81], [@bib88] still had pain at 6 months, although a nonunion was also diagnosed in this patient. Low et al[@bib51], [@bib109] showed an average VAS score for pain on activity of 0.75 of 10 at a mean follow-up of 3.3 years (range, 8 months to 10 years) for patients treated with plating, whereas Zheng et al[@bib51], [@bib109] reported average scores of 3.4, 3, and 2.1 at 3, 6, and 12 months, respectively. The final VAS score was 0 for both patients who had TB in the study by Bartonicek et al[@bib5]. The patient treated with KW in the report by Bourghli and Fabre[@bib8] had no pain by 3 months. The patient treated with a screw and sutures had a VAS score of 0.75 at latest follow-up.[@bib51]

#### Function {#sec2.3.3.2}

The 2 patients managed nonoperatively in the study by Bartonicek et al[@bib5] had Disabilities of the Arm, Shoulder and Hand (DASH) scores of 27.1 at 18 months and 33.3 at 13 months. Among studies that examined plating, 1 case report found a DASH score of 23.33 at 8 weeks[@bib49] whereas the average DASH and QuickDASH (short version of DASH questionnaire) scores at later follow-up assessments (approximately 1 year or later) ranged from 8.6 to 13.5[@bib51]^,^[@bib63]^,^[@bib105] and from 0.66 to 0.81,[@bib23]^,^[@bib89] respectively.; The DASH scores of the 2 patients treated with TB were 25.8 (at 2 years) and 24.2 (at 18 months).[@bib5] The patient treated with a screw and sutures had a DASH score of 9 at latest follow-up.[@bib51]

#### Return to work or activities {#sec2.3.3.3}

Studies investigating plating reported that all patients returned to their preinjury level of work or activity following treatment.[@bib51]^,^[@bib76]^,^[@bib89]^,^[@bib99] The patient treated with KW was able to return to work by 8 months.[@bib8] The patient treated with a screw and suturing also returned to the previous occupation and activity level.[@bib51]

#### Radiographic union {#sec2.3.3.4}

Regarding patients managed nonoperatively, Robinson et al[@bib67], [@bib95] found a nonunion in 2 of 24 patients at the 24-week follow-up, and there were 4 nonunions and 1 malunion among the 55 patients investigated by Van Tongel et al[@bib67], [@bib95]; however, all 4 patients in the study of Singh et al[@bib78] had a successfully united fracture. Most plating studies reported successful union among all patients,[@bib23]^,^[@bib51]^,^[@bib76]^,^[@bib89]^,^[@bib99]^,^[@bib105]^,^[@bib109] but there were 2 exceptions: The patient in the report by Teng and Liu[@bib63], [@bib88] experienced a nonunion at 6 months after plating, and a nonunion occurred in 1 of 9 patients in the study by Oe et al[@bib63], [@bib88]. The patient treated with KW had complete union by 3 months.[@bib8] The case treated with a screw and suturing had successful union as well.[@bib51]

#### Other complications {#sec2.3.3.5}

Bartonicek et al[@bib5] reported 1 case of clavicle shortening in a patient treated nonoperatively. In the study by Frima et al[@bib23], plating caused implant irritation in 8 of 15 patients, leading to implant removal in 7, and there was also 1 case of implant failure and deep infection that required revision surgery. The patient treated with a plate in the case report by Teng and Liu[@bib88], [@bib109] underwent revision for nonunion with a partial claviculectomy, and Zheng et al[@bib88], [@bib109] encountered a redislocation of the sternoclavicular joint in 1 patient (of 12), but this occurred after plate removal. In contrast, other studies on plating revealed no complications or revisions following the procedure.[@bib51]^,^[@bib76]^,^[@bib89]^,^[@bib105] Bartonicek et al also reported slight hypertrophy of the medial clavicle in a patient managed with TB at the 2-year follow-up. No complications were reported in the case treated with a screw and suturing.[@bib51]

Discussion {#sec3}
==========

Midshaft fractures {#sec3.1}
------------------

Operative interventions showed significant improvements over nonoperative methods in terms of early and long-term function, time to radiographic union, and reduction in certain complications. Specifically, plating, the ESIN, and the CRx consistently demonstrated more favorable function than nonoperative therapies over time; the IMP also showed greater function than nonoperative treatments from 6 weeks onward, but its effects were never statistically significant. Moreover, operative treatments demonstrated a significantly earlier time to radiographic union than the sling. Therefore, for patients who seek a quicker recovery, operating would be the best approach. Plating, the IMP, and the ESIN also showed lower risks of nonunion and malunion relative to nonoperative therapies, but only plating had a statistically significant effect compared with each nonoperative treatment. Of note, there were no data for the CRx to include in the analyses of nonunion and malunion. Though not statistically significant, our analysis also revealed that although plating was associated with an increase in ongoing symptoms, except compared with the ESIN, it also had the least risk of a delayed union and revision surgery. Plating showed significant improvements in the greatest number of comparisons across multiple outcomes, followed by the ESIN. The CRx also showed promise as a treatment; however, there is currently limited evidence on this method. Although the IMP similarly showed some statistically significant findings, its effects were not as impressive.

Prior reviews have also demonstrated that operative interventions show improvements over nonoperative treatments in terms of functional outcomes, time to union, and fewer complications, such as nonunion.[@bib16]^,^[@bib66]^,^[@bib96] Virtanen et al[@bib96] found that the results of surgery showed better function and a lower likelihood of delayed union and nonunion. Duan et al[@bib16] suggested that plating results in fewer complications and more satisfaction than use of a sling. More recently, Rehn et al[@bib66] found that nonoperatively treated patients had more nonunions but that operative intervention may increase the risk of minor complications.

In a review, Wang et al[@bib98] suggested that treatment with intramedullary (IM) implants, compared with plating and nonoperative treatment, is the optimal approach. However, they grouped all nonoperative therapies (ie, sling and F8B) and all the various IM devices (ie, IMP and ESIN), and these conclusions were based on nonunion and infection rates, which were higher with plating than with IM fixation but not statistically significant. Jiang et al[@bib33] conducted a network meta-analysis on function and also suggested that IM fixation resulted in more favorable outcomes, but they grouped treatments in a similar fashion to Wang et al (ie, any IM device) and only included studies that used the Constant-Murley score.

Distal fractures {#sec3.2}
----------------

We found that functional improvement at earlier visits may be best achieved with CCSu, although these results were not statistically significant. At ≥1 year, functional scores were significantly worse with KW than with CCSu, CCSu-LP, the HP, and the LP, whereas functional scores with TB-KW were significantly worse than with the LP only. Of note, CCSu-LP was ranked third and second at 3 and 6 months, respectively, and there were no functional data for the LP at 6 months. No significant findings were observed for time to radiographic union, but CCSu-LP showed the earliest time to union and CCSu alone resulted in the longest time. The HP demonstrated the least risk of hardware problems, but this was only significant compared with KW, and the LP and CCSu-LP were ranked second and third, respectively, in this analysis. The risk of a nonunion was most favorable with the LP and CCSu-LP, whereas the sling and CCSu were ranked lowest for this outcome. The LP was ranked second, after TB-KW, for the risk of refracture, whereas CCSu and the HP were ranked lowest. For both the risk of reoperation and symptomatic hardware, CCSu-LP was ranked highest with significantly lower risks than with all other interventions (there were no data for locked plating alone to include in these analyses); CCSu was ranked lowest and had a significantly higher risk of symptomatic hardware compared with all other treatments. Such results suggest that, for early and sustained functional improvement and limited complications, the LP with or without CCSu may provide the most optimal outcome. CCSu alone and the HP may be viable alternatives as well, although CCSu alone appears to be associated with union-related issues and continued symptoms, and both CCSu alone and the HP may have a higher likelihood of refracture.

The network meta-analysis by Boonard et al[@bib7] on distal fractures included 11 studies and evaluated (1) coracoclavicular (CC) fixation, (2) an HP, (3) an LP, (4) TB, and (5) KW. Similarly to our analysis, the authors concluded that CC fixation and the LP were better than both the HP and TB for function and that the LP was associated with a lower risk of complications. Although we came to the same general conclusions, there were some differences in our methodology. First, Boonard et al did not consider some treatments as combination therapies, such as CC fixation with an LP and TB with KW. We considered each combination therapy a treatment node to ensure the effects were exclusively attributed to each unique therapy. Second, Boonard et al analyzed different functional measures separately (ie, Constant-Murley and UCLA scores) and did not evaluate function across different time points. We converted functional measures to a common scale and analyzed these data at 3 months, 6 months, and ≥1 year to determine differences occurred over time. Finally, Boonard et al evaluated the risk of any complication, whereas we assessed specific complications to determined whether particular events were more---or less---likely following a particular treatment.

Medial fractures {#sec3.3}
----------------

Plating appears to be associated with better functional scores than both the sling and TB. In addition, plating, a screw and suturing, and KW were positively associated with a patient\'s return to his or her previous occupation or activity level; however, the latter 2 treatments were limited to evidence from case reports. Surgical intervention also appears to lessen the risk of nonunion and malunion relative to nonoperative therapy. With plating, the most common complaint in 1 study was implant irritation, which led to subsequent implant removal, and there were also 2 cases that underwent revision; however, other studies reported no complications or revisions following plating. The authors of some studies indicated why they selected certain treatments, suggesting that they may have preferred another treatment under other circumstances. Bourghli and Fabre[@bib8] stated that they used KW instead of plating because the fracture was too severely comminuted. Low et al[@bib51] used a screw and suturing instead of plating because the patient had poor bone stock. The patients treated nonoperatively in the study by Bartonicek et al[@bib5] were deemed unfit for surgery: Both patients were elderly, and 1 underwent a prior coronary bypass and the other was a heavy drinker. In other cases, the surgeon chose TB instead of plating because the medial fragment in these patients was too short and there was inadequate bone stock.

The evidence on medial fractures is very limited. Part of the reason for this may be its extremely low prevalence, representing \<3% of clavicle fractures.[@bib72] Our review suggests that plating, given the proper indications, offers the best outcome; however, implant irritation can occur, which is usually resolved with implant removal. Other surgical procedures (ie, TB, KW, screws and suturing) seem to perform well too, but these options may only be preferred in situations in which plating is contraindicated, and the evidence on these treatments is limited to just a few case reports.

Strengths and limitations {#sec3.4}
-------------------------

Our review differentiated between clavicle fracture types (ie, midshaft, distal, and medial) as they are not the same injury. We conducted a comprehensive comparative analysis, for midshaft and distal fractures, of various interventions. We also examined numerous outcomes to best inform treatment decisions when weighing the risks and benefits of these therapies. We were very specific in our categorization of interventions, including combination therapies, so that our results were less likely to be confounded by variations in treatment techniques or characteristics.

A disadvantage of our study is that it includes mostly low-quality studies; however, this is reflective of the current state of the evidence and highlights the need for more high-quality trials. Moreover, because of the limited data, the precision around the effect estimates was very low, and the inclusion of additional evidence in the future may impact the results. In addition, for medial fractures, we found no studies directly comparing treatments, meaning that our conclusions were based on case series and case reports and we could not compare these treatments via a meta-analysis. Another consideration is that fracture characteristics (pattern, stability, amount of displacement, and so on) can play a role in treatment decisions; thus, these data may not be applicable to every patient who sustains a clavicle fracture. The availability of or preference for some of these interventions in certain geographic regions can also influence the applicability of our results. For example, none of the studies evaluating the ESIN for midshaft fractures were conducted in North America. Hence, it is difficult to determine whether the ESIN would be a viable option for North American patients, as their physical characteristics and behaviors may be different from those of patients from other countries; North American surgeons may see less promising results with the ESIN in their patients. Finally, we only included articles published in English and therefore may have missed studies published in other languages.

Conclusion {#sec4}
==========

This study provides evidence to inform treatment decisions for midshaft, distal, and medial clavicle fractures; however, additional high-quality evidence would be impactful. More specifically, future studies should be large (ie, greater sample sizes), multicenter randomized trials. The current evidence suggests that surgery with plating, surgery with an ESIN, and surgery with a CRx are all good options for midshaft fractures; an LP with or without CC suturing should be preferred for distal fractures; and plating is also acceptable for medial fractures, provided that the patient is deemed suitable for surgery and has the adequate bone stock and sufficiently sized medial fragment necessary to implant the device. Patient preferences for certain outcomes should be considered, which may result in different treatment recommendations.
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[^1]: *F8B*, figure-of-eight bandage; *NR*, not reported; *ESIN*, elastic stable intramedullary nail; *CRx*, Sonoma CRx intramedullary nail; *IMP*, intramedullary pin; *IQR*, interquartile range.

[^2]: *CC*, coracoclavicular; *TB*, tension band; *NR*, not reported.

[^3]: *NR*, not reported.

[^4]: *MD*, mean difference; *RR*, risk ratio; *CrI*, credible interval; *ESIN*, elastic stable intramedullary nail; *F8B*, figure-of-eight bandage; *CRx*, Sonoma CRx intramedullary nail; *IMP*, intramedullary pin.

[^5]: Statistically significant.

[^6]: *MD*, mean difference; *RR*, risk ratio; *CrI*, credible interval; *CCSc*, coracoclavicular screw fixation; *LP*, locking plate; *CCSu*, coracoclavicular suturing; *HP*, hook plate; *TB*, tension band; *KW*, K-wires.

[^7]: Statistically significant.
